Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity

v3.22.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2019 $ 6,157,565 $ 6,467 $ 198,975,056 $ 192,823,958  
Beginning balance, shares at Dec. 31, 2019   64,672,893      
Issuance of common stock, net of issuance costs 136,364,901 $ 3,375 136,361,526    
Issuance of common stock, net of issuance costs, shares   33,752,192      
Stock-based compensation expense 12,458,229   12,458,229    
Issuance of common stock upon exercise of stock options $ 756,461 $ 43 756,418    
Issuance of common stock upon exercise of stock options, shares 427,611 427,611      
Fair value of warrants issued $ 807,149   807,149    
Net loss (111,269,380)     (111,269,380)  
Ending balance, value at Dec. 31, 2020 45,274,925 $ 9,885 349,358,378 (304,093,338)  
Ending balance, shares at Dec. 31, 2020   98,852,696      
Issuance of common stock, net of issuance costs 59,110,800 $ 2,554 59,108,246    
Issuance of common stock, net of issuance costs, shares   25,539,585      
Stock-based compensation expense $ 9,480,373   9,480,373    
Issuance of common stock upon exercise of stock options, shares 838,600        
Issuance of common stock upon exercise of warrants $ 944,800 $ 84 944,716    
Issuance of common stock upon exercise of warrants, shares   838,600      
Unrealized gain (loss) on marketable debt securities (62,445)       $ (62,445)
Net loss (45,640,426)     (45,640,426)  
Ending balance, value at Dec. 31, 2021 $ 69,108,027 $ 12,523 $ 418,891,713 $ (349,733,764) $ (62,445)
Ending balance, shares at Dec. 31, 2021   125,230,881